A malariometric survey in a rural community in the Muheza District, Tanzania: Age profiles in the development of humoral immune responses

Acta Tropica

Volumn 68, Issue 2, 1997, Pages 239-253

  Warsame, Marian ^a   Wernsdorfer, Walther H ^b   Perlmann, Hedvig ^a   Lebbad, Marianne ^c   Ericsson, Örjan ^d   Matola, Yohana G ^e   Troye Blomberg, Marita ^a   Perlmann, Peter ^a   Berzins, Klavs ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

Chloroquine; Hematocrit; Malariometric indices; Plasmodium falciparum; Seroepidemiology; Tanzania

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ADOLESCENT; ADULT; AGE; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HEMATOCRIT; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITE PREVALENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; RURAL POPULATION; SEROEPIDEMIOLOGY; SPLENOMEGALY; TANZANIA;

EID: 0030772715     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(97)00100-9     Document Type: Article

References (35)

1. Ahlborg N., Iqbal J., Hansson M.et al. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence. Parasite Immunol. 17:1995;341-352.
2. Astagneau P., Chougnet C., Lepers J.P., Andriamangatiana-Rason M.D., Deloron P. Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf155/RESA) protect against Plasmodium falciparum malaria. Int. J. Epidemiol. 23:1994;169-175.
3. Beck H.P., Felger I., Genton B.et al. Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria. Infect. Immun. 63:1995;596-600.
4. Berzins K., Perlmann H., Wåhlin B.et al. Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf155, react with the native protein and inhibit merozoite invasion. Proc. Natl. Acad. Sci. USA. 83:1986;1065-1069.
5. Berzins K., Perlmann H., Wåhlin B.et al. Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA. Infect. Immun. 59:1991;1500-1506.
6. Boudin C., Sheick I., Chumpitazi B.et al. The multifactorial and multistage character of protective immunity to Plasmodium falciparum, naturally acquired by an indigenous population in Burkina Faso. Scand. J. Immunol. 39:1994;409-417.
7. Bruce-Chwatt, L.J., 1980. Essential Malariology. Heinemann, London, pp. 1-354.
8. Cattani J.A., Tulloch J.L., Vrbova H.et al. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am. J. Trop. Med. Hyg. 35:1986;3-15.
9. Chumpitazi B.F.F., Deloron P., Peyron F., Boudin C., Picot S., Ambroise-Thomas P. Relationships between clinical protection and antibodies to Plasmodium falciparum RESA (ring-infected erythrocyte surface antigen) peptides. Int. J. Parasitol. 21:1991;271-274.
10. Collins W.E., Anders R.F., Pappaioanou M.et al. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature (London). 323:1986;259-262.
11. Coppel R.L., Cowman A.F., Anders R.F.et al. Immune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences. Nature (London). 310:1984;789-791.
12. De Maeyer D., Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat. Q. 38:1985;302-316.
13. Deloron P., Campbell G.H., Brandling-Bennett D.et al. Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villages. Am. J. Trop. Med. Hyg. 41:1989;395-399.
14. Deloron P., Cot M. Antibodies to the ring-infected erythrocyte surface antigen and the circumsporozoite protein of Plasmodium falciparum in a rural community from Burkina Faso. Trans. R. Soc. Trop. Med. Hyg. 84:1990;191-195.
15. Foster S. Treatment of malaria outside the formal health services. J. Trop. Med. Hyg. 98:1995;29-34.
16. Gysin J., Gavoille S., Mattei D.et al. In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for sub-unit vaccine against the asexual blood stage of Plasmodium falciparum. J. Immunol. Methods. 159:1993;209-219.
17. Hackett L.W. Spleen measurement in malaria. J. Natl. Soc. 3:1944;121-133.
18. Hellgren U., Ericsson O., Kihamia C.M., Rombo L. Malaria parasites and chloroquine concentrations in Tanzanian school children. Trop. Med. Parasitol. 45:1994;293-297.
19. Iqbal J., Perlmann P., Greenwood B.M., Berzins K. Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions. Clin. Exp. Immunol. 94:1993;68-74.
20. Iqbal J., Rab A., Perlmann P., Berzins K. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan). Am. J. Trop. Med. Hyg. 51:1994;444-453.
21. Kilimali V.A.E.B., Mkufya A.R. In vivo and in vitro assessment of the sensitivity of Plasmodium falciparum to chloroquine in four districts of Tanga region, Tanzania. Trans. R. Soc. Trop. Med. Hyg. 79:1985;478-481.
22. Lindström B., Ericsson Ö., Alvan G. Determination of chloroquine and its desethyl-metabolite in whole blood: an application for sample collected in capillary tubes and dried on filter paper. Ther. Drug Monit. 7:1985;207-210.
23. Marsh K., Otoo L., Hayes R.J., Carson D.C., Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 83:1989;293-303.
24. Mattei D., Scherf A. The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes. Gene. 110:1992;71-79.
25. McGregor I.A. Demographic effects of malaria with special reference to stable malaria of Africa. W. Afr. Med. J. 9:1960;260-265.
26. Mnzava A.E.P., Kilama W.L. Observation on the distribution of the Anopheles gambiae complex in Tanzania. Acta Trop. 43:1986;277-282.
27. Perlmann H., Berzins K., Wahlgren M.et al. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early stages of Plasmodium falciparum. J. Exp. Med. 159:1984;1686-1704.
28. Perlmann H., Perlmann P., Berzins K.et al. Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol. Rev. 112:1989;115-132.
29. Perlmann P., Berzins K., Perlmann H., Troye-Blomberg M., Wahlgren M., Wåhlin B. Malaria vaccines: immunogen selection and epitope mapping. Vaccine. 6:1988;183-187.
30. Petersen E., Högh B., Marbiah N.T.et al. A longitudinal study of antibodies to the Plasmodium falciparum antigen Pf155/RESA and immunity to malaria infection in adult Liberians. Trans. R. Soc. Trop. Med. Hyg. 84:1990;339-345.
31. Premji Z., Hamisi Y., Shiff C., Minjas J., Lubega P., Makwaya C. Anaemia and Plasmodium falciparum infections among young children in an holoendemic area, Bagamoyo, Tanzania. Acta Trop. 59:1995;55-64.
32. Riley E.M., Allen S.J., Troye-Blomberg M.et al. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of West Africa. Trans. R. Soc. Trop. Med. Hyg. 85:1991;436-443.
33. Wahlgren M., Berzins K., Perlmann P., Björkman A. Characterzation of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA. Clin. Exp. Immunol. 53:1983;127-134.
34. Wahlgren M., Björkman A., Perlmann H., Berzins K., Perlmann P. Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am. J. Trop. Med. Hyg. 35:1986;22-29.
35. r 155 000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc. Natl. Acad. Sci. USA. 81:1984;7912-7916.